Investor Interest Surges as Teladoc Health Beats Revenue Expectations
Teladoc Health reported better-than-expected financial results for the second quarter, with revenue increasing 10% year-over-year to $652.4 million. The company's adjusted gross margin improved, and adjusted EBITDA was up 54% year-over-year. Teladoc expects third-quarter revenue in the range of $650 million to $675 million and full-year 2023 revenue between $2.6 billion and $2.675 billion. Teladoc shares were up 7.46% following the news.